188 related articles for article (PubMed ID: 11201042)
1. Osteoprotegerin and osteoclast differentiation factor in tooth eruption.
Wise GE; Lumpkin SJ; Huang H; Zhang Q
J Dent Res; 2000 Dec; 79(12):1937-42. PubMed ID: 11201042
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption.
Wise GE; Yao S; Zhang Q; Ren Y
Arch Oral Biol; 2002 Mar; 47(3):247-54. PubMed ID: 11839361
[TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle.
Liu D; Yao S; Wise GE
Eur J Oral Sci; 2006 Feb; 114(1):42-9. PubMed ID: 16460340
[TBL] [Abstract][Full Text] [Related]
4. Injections of osteoprotegerin and PMA delay tooth eruption.
Wise GE; Yao S; Liu D
Clin Anat; 2006 Jan; 19(1):19-24. PubMed ID: 16283633
[TBL] [Abstract][Full Text] [Related]
5. CSF-1 regulation of osteoclastogenesis for tooth eruption.
Wise GE; Yao S; Odgren PR; Pan F
J Dent Res; 2005 Sep; 84(9):837-41. PubMed ID: 16109994
[TBL] [Abstract][Full Text] [Related]
6. CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption.
Heinrich J; Bsoul S; Barnes J; Woodruff K; Abboud S
Arch Oral Biol; 2005 Oct; 50(10):897-908. PubMed ID: 16137499
[TBL] [Abstract][Full Text] [Related]
7. Chronology and regulation of gene expression of RANKL in the rat dental follicle.
Liu D; Yao S; Pan F; Wise GE
Eur J Oral Sci; 2005 Oct; 113(5):404-9. PubMed ID: 16202028
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
[TBL] [Abstract][Full Text] [Related]
9. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
11. A novel molecular mechanism modulating osteoclast differentiation and function.
Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Goto M; Mochizuki SI; Tsuda E; Morinaga T; Udagawa N; Takahashi N; Suda T; Higashio K
Bone; 1999 Jul; 25(1):109-13. PubMed ID: 10423033
[TBL] [Abstract][Full Text] [Related]
12. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts.
Tada T; Jimi E; Okamoto M; Ozeki S; Okabe K
Int J Cancer; 2005 Aug; 116(2):253-62. PubMed ID: 15800904
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
Liu XH; Kirschenbaum A; Yao S; Levine AC
Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway.
Fukushima H; Jimi E; Kajiya H; Motokawa W; Okabe K
J Dent Res; 2005 Apr; 84(4):329-34. PubMed ID: 15790738
[TBL] [Abstract][Full Text] [Related]
15. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
16. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
Hofbauer LC; Khosla S; Dunstan CR; Lacey DL; Boyle WJ; Riggs BL
J Bone Miner Res; 2000 Jan; 15(1):2-12. PubMed ID: 10646108
[TBL] [Abstract][Full Text] [Related]
17. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
[TBL] [Abstract][Full Text] [Related]
18. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
19. Dental cells express factors that regulate bone resorption.
Rani CS; MacDougall M
Mol Cell Biol Res Commun; 2000 Mar; 3(3):145-52. PubMed ID: 10860862
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption.
Kostenuik PJ; Shalhoub V
Curr Pharm Des; 2001 May; 7(8):613-35. PubMed ID: 11375772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
